🧬 PANCRAGEN: WHAT IS IT? Pancragen shows up on a lot of bioregulator lists. Here's what it is in plain English. WHAT IT IS • A short lab-made peptide (4 amino acids) from the Khavinson bioregulator family • Linked to pancreas tissue — the organ that makes insulin and digestive enzymes • Sequence often written as Lys-Glu-Asp-Trp (KEDW) WHAT PEOPLE LOOK AT IT FOR • Healthy-aging interest around pancreas and metabolic support • Research talk about pancreas tissue and gene activity • Not the same as insulin, metformin, or any approved diabetes medicine WHAT THE RESEARCH ACTUALLY SHOWS • Cell and tissue studies on pancreas-related gene activity • Rodent work on aging and pancreas tissue • Almost all of it comes from one research group in Russia • No large independent human trials that prove a clinical benefit Evidence level: Early (cell/animal; single research lineage). GOOD TO KNOW • Not FDA approved for any use • Not a blood-sugar treatment and not a substitute for prescribed care • "Pancreas" on the label does not mean it rebuilds or fixes that organ in people HOW TO READ A COA (IF YOU SEE ONE) • Name and lot number match the vial • Mass spec matches the expected peptide weight • HPLC purity with a recent test date • A third-party lab you can look up yourself For research use only, not medical advice. Takeaway: Pancragen is an early-stage pancreas-linked bioregulator idea from one research line, not a proven pancreas fix. Get the full research library, 20+ graded vendors and weekly $/mg in Premium — $9/mo with 7 days free 👉 https://www.skool.com/peptideindex/about

Vilon is one of the smallest names on any bioregulator list. Here's what it actually is in plain English. WHAT IT IS Vilon is a tiny synthetic peptide made of just 2 amino acids, lysine and glutamic acid (Lys-Glu, or KE). It comes from the Russian bioregulator research line (the Khavinson group). It's described as a thymus-associated, immune-focused peptide. The thymus is the gland that helps train your immune cells, and it naturally shrinks as you age. WHAT PEOPLE USE IT FOR • General immune "support" • Healthy-aging and longevity interest • Some people include it in broader bioregulator rotations WHAT THE RESEARCH ACTUALLY SHOWS • Most of the work is cell and rodent research, nearly all from the same research circle that developed it. • Those studies look at things like immune cell activity, gene activity in aging cells and thymus tissue in older animals. Interesting, but not proof of anything in people. • There are no large, independent human trials on Vilon itself. • Evidence level: Very Early (cell/animal work, single research lineage, no solid human trials). COMMON QUESTIONS Is it the same as Thymalin? No. Thymalin is a thymus extract with many components. Vilon is one defined 2-amino-acid peptide. Is it the same as Thymosin Alpha-1? No. Thymosin Alpha-1 is a much longer peptide with real human trial data and approvals in some countries. Vilon doesn't have that track record. Can something that small really do much? That's the big open question. Small size makes it easy to make, but it doesn't prove it works. EASY WAY TO REMEMBER IT Vilon = the 2-amino-acid thymus bioregulator. Simple molecule, early lab data. For research use only, not medical advice. Takeaway: Vilon has a neat story and interesting lab work, but the human evidence just isn't there yet. Exact dosing and timing are in the Premium ⏱️ Dosage & Timing classroom: https://www.skool.com/peptideindex/about Want the best vendor for the best mg-for-price? Unlock it with Premium for $9/mo: https://www.skool.com/peptideindex/about

Prostamax comes up a lot in bioregulator lists aimed at men over 40. Here's what it actually is in plain English. WHAT IT IS Prostamax is a short synthetic peptide from the Russian bioregulator research line (the Khavinson group). It's usually described as a 4-amino-acid peptide (Lys-Glu-Asp-Pro, or KEDP) designed to mimic signals from prostate tissue. It's the lab-made cousin of older prostate tissue extracts used in Russia. Extract and synthetic peptide are not the same thing, even when they get lumped together. WHAT PEOPLE USE IT FOR • General prostate "support" as they age • Urinary comfort and flow • Anti-aging for prostate tissue • Some people add it to broader men's health bioregulator cycles WHAT THE RESEARCH ACTUALLY SHOWS • Most of the data is cell and tissue-culture work, mostly from the same research circle that created it. • Those lab studies look at things like gene activity and how "young" aging cells behave. That's interesting, but it isn't the same as proof it helps a real prostate. • There are no large, independent, placebo-controlled human trials on Prostamax itself. • Evidence level: Very Early (cell/tissue work, single research lineage, no solid human trials). COMMON QUESTIONS Is it a treatment for an enlarged prostate? No. Nothing here shows it treats BPH, prostatitis or anything else. Those have proven options a doctor can walk you through. Does it affect testosterone? There's no good evidence it does. It's not TRT and not a T booster. Is it the same as Testagen? No. Testagen is the testis-associated bioregulator. Prostamax is the prostate one. EASY WAY TO REMEMBER IT Prostamax = the prostate bioregulator. Big claims, early lab data. BOTTOM LINE An interesting research peptide with a tidy story behind it, but the human evidence just isn't there yet. If you're dealing with prostate symptoms, get checked out first, since PSA and an exam matter more than any peptide. This is education only, not medical advice. We'll keep going one compound at a time in plain English.

Testagen is the "testes / male hormones" name on most bioregulator lists. That label makes it sound like a testosterone tool. The research behind it is much thinner than the name suggests. Here's the simple version. WHAT IT IS Testagen is a short lab-made peptide of four amino acids: lysine, glutamic acid, aspartic acid, and glycine (written Lys-Glu-Asp-Gly, or KEDG). It comes from the Khavinson bioregulator program in St. Petersburg, Russia, the same group behind Epitalon, Pinealon, and Cardiogen. In that framework, tiny tissue-specific peptides are supposed to nudge gene activity in the organ they are named for. For Testagen, that organ is the testes. WHAT PEOPLE USE IT FOR • Male hormone and "andropause" conversations in the longevity community • Fertility / sperm-quality talk online • Stacking with other Khavinson bioregulators (and sometimes with TRT-adjacent compounds) WHAT THE RESEARCH ACTUALLY SHOWS • Peer-reviewed animal work on this sequence: the published KEDG papers that are easiest to find are not testis studies. They look at thyroid and thymus recovery in birds after the pituitary was removed. That is interesting biology, but it is not a testosterone or sperm trial. • Lab chemistry: other papers from the same lineage describe how short peptides like this can bind DNA or histone proteins in a dish. • Testis claims: a Russian clinical-experimental write-up from the originating group describes rat testis tissue growing in a dish and some fertility protection in irradiated male rats. The same write-up describes a small study in older men. That report is not a peer-reviewed journal article with full methods, has no clear placebo/blinding description, and has not been independently repeated. • Humans: there is no registered ClinicalTrials.gov study for Testagen, and no independent controlled trial that proves it raises testosterone or fixes fertility. Evidence level: Very Early. A small set of papers from one research lineage, mostly non-testis models for the peer-reviewed work, plus unverified testicular and human claims. Not a proven hormone treatment.

🧬 CARTALAX: WHAT IS IT? Cartalax is the "joint / cartilage" name on most bioregulator lists. People talk about it for knees, cartilage, and aging joints. The published research is still mostly cells in a dish from one research group. Here's the simple version. WHAT IT IS Cartalax is a short lab-made peptide of three amino acids: alanine, glutamic acid, and aspartic acid (written Ala-Glu-Asp, or AED). In older papers from the same group it also shows up as T-31. It comes from the Khavinson bioregulator program in St. Petersburg, Russia — the same lineage as Epitalon, Cortagen, and Livagen. It was designed as a small synthetic stand-in for ideas behind a cartilage-and-bone tissue extract (often discussed alongside a complex called Sigumir). WHAT PEOPLE USE IT FOR • Joint and cartilage support talk in the longevity community • Connective-tissue and "aging chondrocyte" conversations • Stacking talk with other short Khavinson peptides WHAT THE RESEARCH ACTUALLY SHOWS • Human stem cells in a dish (2023): AED raised markers that cartilage-forming cells use to build matrix — including SOX9, aggrecan, type II collagen, and COMP — in aged mesenchymal stem cells (Linkova / Khavinson group). • Aging cartilage cells in a dish (2023): AED helped normalize a senescence-style profile (raised p16, p21, p53, and some inflammatory signals; lowered Sirt1) in aged chondrocytes from the same research lineage. • Animals: indexed living-animal work is thin. A 2007 rat bone-density study compared a cartilage extract with "T-31" (later identified as AED); the extract did better. A developer's 2023 review mentions osteoarthritis models and older patients taking it by mouth, but those joint studies are not sitting as clear, independently indexed trials you can pull up the way you would a big RCT. • Humans: no controlled, registered clinical trial of Cartalax/AED for joint disease was found on ClinicalTrials.gov. Evidence level: Very Early. Cell studies (and limited related animal work), nearly all from one research lineage, with no independent replication and no solid human outcome data for cartilage repair.